Citations

Clear

4610 citation(s) found for "Lu, Brian".

Experts Achieve Consensus on a Majority of Statements Regarding Platelet‐Rich Plasma Treatments for Treatment of Musculoskeletal Pathology
Hurley, Eoghan T. , Sherman, Seth L. , Stokes, Daniel J. , Shapiro, Shane A. , Mautner, Kenneth , Buford, Don , Dragoo, Jason L. , Mandelbaum, Bert R. , Zaslav, Kenneth R. , Cole, Brian J. , Hall, Mederic M. , Piuzzi, Nicolás S. , Shapiro, Shane , Mautner, Kenneth R , Rodeo, Scott A. , Frank, Rachel M , Kon, Elizaveta

Mayo Clinic

Arthroscopy | August 23, 2023 | Volume: 40 | Issue: 2 | Pages: 470

10.1016/j.arthro.2023.08.020 | PMID 37625660 Get It

Purpose To establish consensus statements on platelet‐rich plasma (PRP) for the treatment of musculoskeletal pathologies. Methods A consensus process on the treatment of PRP using a modified Delphi technique was conducted. Thirty‐five orthopaedic surgeons and sports medicine physicians participated in these consensus statements on PRP. The participants were composed of representatives of the Biologic Association, representing 9 international orthopaedic and musculoskeletal professional societies invited due to their active interest in the study of orthobiologics. Consensus was defined as achieving 80% to 89% agreement, strong consensus was defined as 90% to 99% agreement, and unanimous consensus was indicated by 100% agreement with a proposed statement. Results There was consensus on 62% of statements about PRP. Conclusions (1) PRP should be classified based on platelet count, leukocyte count, red blood count, activation method, and pure‐plasma versus fibrin matrix; (2) PRP characteristics for reporting in research studies are platelet count, leukocyte count, neutrophil count, red blood cell count, total volume, the volume of injection, delivery method, and the number of injections; (3) the prognostic factors for those undergoing PRP injections are age, body mass index, severity/grade of pathology, chronicity of pathology, prior injections and response, primary diagnosis (primary vs postsurgery vs post‐trauma vs psoriatic), comorbidities, and smoking; (4) regarding age and body mass index, there is no minimum or maximum, but clinical judgment should be used at extremes of either; (5) the ideal dose of PRP is undetermined; and (6) the minimal volume required is unclear and may depend on the pathology. Level of Evidence Level V, expert opinion.
P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS
Jun, Monika, Wang, Tongsheng , Mutebi, Alex , Osei-Bonsu, Kojo, Elliott, Brian , Kalsekar, Anupama, Navarro, Fernando Rivas, Rosenthal, Allison , Muñoz, Javier , Wang, Anthony , Yang, Shibing , Ip, Andrew

Mayo Clinic

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e9299527

10.1097/01.hs9.0000971492.92995.27 Get It

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
Acosta‐Medina, Aldo A. , Kemps, Paul G. , Zondag, Timo C. E. , Abeykoon, Jithma P. , Forma-Borst, Jelske, Steenwijk, Eline C., Feijen, Elizabeth A. M. , Teepen, Jop C. , Bennani, N. Nora , Schram, Susan, Davidge‐Pitts, Caroline , Ryu, Jay H. , Vassallo, Robert , Dasari, Surendra , Ravindran, Aishwarya , Cleven, Arjen H.G. , Balgobind, Brian V. , Saeed, Peerooz , Bramer, Jos A. M. , Groen, Ruben A. L. de , Tonino, Sanne H. , Bos, Cor van den , Laar, Jan van , Halteren, Astrid G. S. van , Schram, Susan M, Shah, Mithun V , Davidge-Pitts, Caroline , Koster, Matthew J , Ryu, Jay H , Tobin, W Oliver , Young, Jason R , Dasari, Surendra , Rech, Karen , Ravindran, Aishwarya , Cleven, Arjen H G , Verdijk, Robert M , van Noesel, Carel J M , Balgobind, Brian V , Bouma, Gerrit Joan , Saeed, Peerooz , Bramer, Jos A M , de Groen, Ruben A L , Vermaat, Joost S P , van de Sande, Michiel A J , Smit, Egbert F , Langerak, Anton W , van Wezel, Tom , Tonino, Sanne H , van den Bos, Cor , van Laar, Jan A M , Go, Ronald S , Goyal, Guarav , van Halteren, Astrid G S , Vassallo, Robert , Bennani, N Nora , Acosta-Medina, Aldo A , Shah, Meera , Koster, Matthew J. , Tobin, W. Oliver , Young, Jason R. , Rech, Karen L. , Verdijk, Robert M. , Noesel, Carel J.M. van , Sande, Michiel A. J. van de , Langerak, Anton W. , Go, Ronald S. , Goyal, Gaurav

Mayo Clinic

Blood | August 18, 2023 | Volume: 142 | Issue: 18 | Pages: 1570-1575

10.1182/blood.2023021212 | PMID 37595284 Get It

Abstract In this retrospective study, BRAF mutation status did not correlate with disease extent or (event-free) survival in 156 adults with Langerhans cell histiocytosis. BRAFV600E was associated with an increased incidence of second malignancies, often comprising hematological cancers, which may be clonally related.
Minimum 10-Year Clinical Outcomes and Survivorship of Meniscal Allograft Transplantation With Fresh-Frozen Allografts Using the Bridge-in-Slot Technique
Cotter, Eric J. , Gilat, Ron , Meeker, Zachary D. , Frazier, Landon P., Yanke, Adam B. , Cole, Brian J. , Wagner, Kyle R. , Kaiser, Joshua T. , Hevesi, Mario , Frazier, Landon P.

Mayo Clinic

The American Journal of Sports Medicine | August 18, 2023 | Volume: 51 | Issue: 11 | Pages: 2954-2963

10.1177/03635465231188657 | PMID 37594374 Get It

Background: Meniscal allograft transplantation (MAT) has been shown to provide clinical benefits in patients with symptomatic meniscal deficiency in the short term and midterm. There is, however, a paucity of data regarding long-term outcomes after MAT using fresh-frozen allografts and the bridge-in-slot technique. Purpose: To report clinical outcomes and revision rates after primary MAT with fresh-frozen allografts and the bridge-in-slot technique in a large case series of patients at a 10-year minimum follow-up. Study Design: Case series; Level of evidence, 4. Methods: A retrospective review of prospectively collected data was performed on patients undergoing primary MAT between 2001 and 2012. Lysholm, International Knee Documentation Committee subjective form, and Knee injury and Osteoarthritis Outcome Score subscales were collected preoperatively and at 1-, 2-, 5-, and minimum 10-year follow-ups. Cox proportional hazards modeling was used to identify variables associated with reoperation and failure, defined as revision MAT or conversion to arthroplasty. Reoperation was defined as a subsequent surgical intervention on the transplanted meniscus, including partial or total meniscectomy, meniscal repair, or failure as defined in the previous sentence. Results: A total of 174 patients undergoing MAT met the inclusion criteria and were followed for a mean of 12.7 ± 2.7 years (range, 10.0-21.0 years). The mean age at surgery was 28.3 ± 10.1 years. The patients were predominantly female (n = 92; 53%), and medial MAT was the most commonly performed procedure (n = 91; 52%). Concomitant procedures were performed in 115 patients (66%), with the most common procedure being osteochondral allograft transplantation (n = 59; 34%). Patients demonstrated statistically significant postoperative improvements at all time points for all patient-reported outcome measures ( P ≤ .0001). A total of 65 patients (37%) underwent a meniscal reoperation at a mean time of 6.6 ± 5.5 years (range, 0.3-16.7 years) postoperatively. A total of 40 patients (23%) met the criteria for failure at a mean time of 7.3 ± 5.0 years (range, 1.0-17.4 years) after MAT, with 22 of these patients having undergone a previous meniscal reoperation. At the final follow-up, 13 patients (7%) had undergone revision MAT and 27 (15%) had converted to arthroplasty. The MAT survival rates free of meniscal reoperation and failure were 73% and 85% at 10 years and 60% and 72% at 15 years, respectively. At the time of the final follow-up, 86% of patients reported that they were satisfied with their overall postoperative condition. Conclusion: Primary MAT demonstrates efficacy and durability with high rates of patient satisfaction at a minimum 10-year follow-up. Patients should be counseled that although reoperation rates may approach 40% at 15 years, rates of overall revision MAT and conversion to arthroplasty remain low at long-term follow-up.
Prognostic significance of haemodynamic parameters in patients with cardiogenic shock
Berg, David D. , Baird-Zars, Vivian M., Alviar, Carlos L. , Barsness, Gregory W. , Burke, James A. , Chonde, Meshe , Cooper, Howard A., Daniels, Lori B. , Dodson, Mark , Gidwani, Umesh , Goldfarb, Michael , Guo, Jianping , Hillerson, Dustin , Kenigsberg, Benjamin B. , Kochar, Ajar , Kontos, Michael C. , Lopes, Mathew S. , Loriaux, Daniel B. , Miller, P. Elliott , O’Brien, Connor , Papolos, Alexander , Patel, Siddharth M. , Pisani, Barbara , Prasad, Rajnish, Smith, Timothy D., Teuteberg, Jeffrey J. , Thompson, Andrea D. , Zakaria, Sammy , Katz, Jason N. , Goldfarb, Michael , Kochar, Ajar , Patel, Siddharth M , Solomon, Michael A , van Diepen, Sean , Goldfarb, Michael , Daniels, Lori B , Goldfarb, Michael , Berg, David , Thompson, Andrea , Zakaria, Sammy , Chonde, Meshe D , O'Brien, Connor G , Hillerson, Dustin , Kaur, Gurleen , Bohula, Erin A. , Barnett, Christopher F. , Burke, James A, Chaudhry, Sunit‐Preet , Gerber, Daniel , Ghafghazi, Shahab , Kwon, Younghoon, Potter, Brian J , Prasad, Rajnish, Roswell, Robert O. , Shah, Kevin S , Sinha, Shashank S , Solomon, Michael A. , Diepen, Sean van , Morrow, David A.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | August 16, 2023 | Volume: 12 | Issue: 10 | Pages: 651-660

10.1093/ehjacc/zuad095 | PMID 37640029 Get It

Abstract Aims Invasive haemodynamic assessment with a pulmonary artery catheter is often used to guide the management of patients with cardiogenic shock (CS) and may provide important prognostic information. We aimed to assess prognostic associations and relationships to end-organ dysfunction of presenting haemodynamic parameters in CS. Methods and results The Critical Care Cardiology Trials Network is an investigator-initiated multicenter registry of cardiac intensive care units (CICUs) in North America coordinated by the TIMI Study Group. Patients with CS (2018–2022) who underwent invasive haemodynamic assessment within 24 h of CICU admission were included. Associations of haemodynamic parameters with in-hospital mortality were assessed using logistic regression, and associations with presenting serum lactate were assessed using least squares means regression. Sensitivity analyses were performed excluding patients on temporary mechanical circulatory support and adjusted for vasoactive-inotropic score. Among the 3603 admissions with CS, 1473 had haemodynamic data collected within 24 h of CICU admission. The median cardiac index was 1.9 (25th–75th percentile, 1.6–2.4) L/min/m2 and mean arterial pressure (MAP) was 74 (66–86) mmHg. Parameters associated with mortality included low MAP, low systolic blood pressure, low systemic vascular resistance, elevated right atrial pressure (RAP), elevated RAP/pulmonary capillary wedge pressure ratio, and low pulmonary artery pulsatility index. These associations were generally consistent when controlling for the intensity of background pharmacologic and mechanical haemodynamic support. These parameters were also associated with higher presenting serum lactate. Conclusion In a contemporary CS population, presenting haemodynamic parameters reflecting decreased systemic arterial tone and right ventricular dysfunction are associated with adverse outcomes and systemic hypoperfusion.
Treatment of Ruptured Wide‐Necked Aneurysms using a Microcatheter Injectable Biomaterial
Zhang, Zefu , Albadawi, Hassan , Fowl, Richard J., Mayer, Joseph L. , Chong, Brian W. , Öklü, Rahmi , Oklu, Rahmi

Mayo Clinic

Advanced Materials | August 14, 2023 | Volume: 35 | Issue: 46 | Pages: No page available

10.1002/adma.202305868 | PMID 37579579 Get It

Abstract Ruptured wide‐neck aneurysms (WNAs), especially in a setting of coagulopathy, are associated with significant morbidity and mortality. It is shown that by trapping a sub‐millimeter clinical catheter inside the aneurysm sac using a flow diverter stent (FDS), instant hemostasis can be achieved by filling the aneurysm sac using a novel biomaterial, rescuing catastrophic bleeding in large‐animal models. Multiple formulations of a biomaterial comprising gelatin, nanoclay (NC), and iohexol are developed, optimized, and extensively tested in vitro to select the lead candidate for further testing in vivo in murine, porcine, and canine models of WNAs, including in a subset with aneurysm rupture. The catheter‐injectable and X‐ray visible versions of the gel embolic agent (GEA) with the optimized mechanical properties outperform control groups, including a subset that receive a clinically used liquid embolic (Onyx, Medtronic), with and without aneurysm rupture. A combinatorial approach to ruptured WNAs with GEA and FDS may change the standard of medical practice and save lives.
P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Abonour, Rafat , Rifkin, Robert M. , Gasparetto, Christina, Durie, Brian G.M. , Terebelo, Howard R. , Narang, Mohit , Toomey, Kathleen, Tang, Yuexin , Dhanasiri, Sujith, Anand, Jasmeet, Yu, Edward, Marshall, Thomas, Liu, Liang , Ailawadhi, Sikander , Lee, Hans C. , Wagner, Lynne I. , Hardin, James W. , Jagannath, Sundar

Mayo Clinic

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e52503e2

10.1097/01.hs9.0000970564.52503.e2 Get It

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
Núñez, Jorge, Munshi, Nikhil C. , Durie, Brian G.M. , Paiva, Bruno , Zherniakova, Anastasiia , Rodríguez‐Otero, Paula , Shi, Qian , Miguel, Jesús F. San

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e04566c4

10.1097/01.hs9.0000970708.04566.c4 Get It

Case series: The use of spermatic cord block in maximising patient comfort during ultrasound‐guided percutaneous core‐needle biopsy of the testicle
Dunlay, Michael , Gu, Chris N., Welch, Brian T. , Packard, Annie T. , Atwell, Thomas D. , Gu, Chris, Adamo, Daniel, Welch, Brian, Packard, Annie, Atwell, Thomas, Adamo, Daniel A.

Mayo Clinic

Australasian Journal of Ultrasound in Medicine | August 8, 2023 | Volume: 26 | Issue: 4 | Pages: 267-271

10.1002/ajum.12356 | PMID 38098616 Get It

AbstractIntroduction/PurposePercutaneous core‐needle biopsy of the testicle has been shown to be a safe and effective method of obtaining tissue for histological analysis and can be considered in specific clinical scenarios. While the use of spermatic cord block has been shown to be effective in pain relief in the emergent setting and as an anaesthetic option for inguinal surgery, its use in percutaneous core‐needle biopsy has not been well described. Through this case series, we present our experience and technique of ultrasound‐guided percutaneous core‐needle biopsy using spermatic cord block in the setting of indeterminant testicular masses.MethodsOur departmental biopsy database was reviewed to identify patients who underwent percutaneous core‐needle biopsy of the testicle from March 2010 to July 2022 and who also received spermatic cord block during the procedure.ResultsThree patients were identified who met the search criteria. All three patients presented for the evaluation of indeterminant testicular mass and had a known non‐testicular primary cancer diagnosis at the time of biopsy. All three biopsies were performed using a combination of spermatic cord block, moderate sedation, and local anaesthetic. Biopsies were obtained using an 18‐gauge spring‐loaded device with 4‐5 core samples obtained during each procedure. All biopsies were well tolerated without significant pain or post‐procedure complications.DiscussionUltrasound‐guided percutaneous core‐needle testicular biopsy using spermatic cord block is a safe and effective option in sampling indeterminate testicular masses while maintaining patient comfort.ConclusionThe inclusion of a spermatic cord block in combination with local anaesthetic and moderate sedation has become standard practice in our institution, as we believe this maximises patient comfort and safety resulting in a better patient experience.